Past Events

September 27, 2012
Biologics and Biosimilars
Mary Westrick, vice president, Phase I Quintiles, Overland Park, Kan.

July 17, 2012
Designing and Implementing Viral Clearance Operations during Manufacturing of Anitbodies
Hemant Joshi, Ph.D.

October 21, 2010
The Clinical Significance of Drug Transporters in Drug Disposition and Drug Interactions
Thomas N. Thompson, Ph.D., R&D Services Pharma Consulting